Semaglutide Tirzepatide เปปไทด์ลดน้ำหนัก CAS: 2023788-19-2

1 บาท

ขาย
Amy | Sales manager




ANHUI SHENGZHIKAI BIOTECHNOLOGY CO.,LTD.



Phone:+86 19155187336(whatsapp)


Email:shengzhikai3@shengzhikai.com


Address: 903, block B, Fortune Plaza, Luyang District, Hefei City, Anhui Province





Product Description






High Purity Tirzepatide Raw Powder CAS 2023788-19-2




Detailed Product Information





Tirzepatide CAS 2023788-19-2 Research Chemical with Best Price

Product Name :Tirzepatide

Trade Name: M ounjaro

CAS No.:2023788-19-2


Purity : 98% HPLC

Appearance:  Lyophilized Powder

Typical useweight loss peptides

Shelf Life :2 years


Storage:Refrigeration keep dry and away from light.



Description:



Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. 



Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.

Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.

We conducted the SURPASS-2 trial (A Study of Tirzepatide [LY3298176] versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants with Type 2 Diabetes) to compare the efficacy and safety of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with those of semaglutide at a dose of 1 mg in patients with type 2 diabetes that had been inadequately controlled with metformin monotherapy.





R ybelsus (semaglutide) is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

R ybelsus is usually given after other diabetes medicines have been tried without success.

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.



Weekly semaglutide 2.4 mg (W egovy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²



Semaglutide 1 mg injection (O-zempic) was first approved as a treatment for type 2 diabetes in 2017.


Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placebo



Semaglutide 2.4 mg should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs and herbal products, according to the release. Semaglutide 2.4 mg has not been studied in patients with a history of pancreatitis.




This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it. This is another tool that will allow clinicians to better manage obesity.



High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 TirzepatideHigh Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 TirzepatideHOT SELLING 



































































CAS    Common Name
910463-68-2 Semaglutide acetate salt
2023788-19-2 Tirzepatide
28578-16-7  PMK ethyl glycidate
20320-59-6  Diethyl(phenylacetyl)malonate
288573-56-8 tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate
236117-38-7 2-iodo-1-p-tolylpropan-1-one
102-97-6 Benzylisopropylamine
52190-28-0 2-Bromo-3',4'-(methylenedioxy)p-ropiophenone
2114-39-8 2-bromo-1-phenylpropane
23076-35-9 Xylazine hydrochloride
5061-21-2 3-Bromdihydrofuran-2(3H)-on
59-67-6 Nicotinic acid
50-56-6 Oxytocin acetate salt
132112-35-7 Ropivacaine hydrochloride



High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 TirzepatideHigh Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide

Company information 





Anhui shengzhikai Biotechnology Co., Ltd. is a high-tech enterprise dedicated to the fields of fine chemical products. The scope of products covers pharmaceutical intermediates, plant extracts, chemical reagent, animal pharmaceutical, agrochemical intermediates, antibiotic and so on.



Our customers are all over the world, mainly selling in the United States, Canada, Australia, the United Kingdom, the Netherlands, Germany, France and other EU countries, Southeast Asia, South America, and Oceania. We also have many customers.



Our business is based on honesty and mutual trust. Sincerely look forward to establishing long-term mutually beneficial business relationships with customers around the world.


 


High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide




Certificate





High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide


High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide


High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide




Exhibition





High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide


High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide




Packing & Shipping 

High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 TirzepatideHigh Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide

Payment 

High Purity Peptides Powder Semaglutide Liraglutide CAS 2023788-19-2 Tirzepatide



FAQ

Q: How to start orders or make payments?

A:You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by Trade Manager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.

Q: How to confirm the Product Quality before placing orders?

A:You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples. You can send us your product specifications and requests,we will manufacture the products according to your requests.

Q: What's your MOQ?

A:For the high value product, our MOQ starts from 1g and generally starts from 10gs. For other low price product, our MOQ starts from 100g and 1kg.

Q: Is there a discount?

A: Yes, for larger quantity, we always support with better price.

Q:How do you treat quality complaint?

First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.

Q:How to contact us ?


 

You can choose your interested products and send inquiry to us.

You can dial our telephone directly, you will get our reply.